BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 12, 2010
View Archived Issues
Alexza Takes Tumble on FDA Rejection; No Surprise for Jazz
Read More
Biotech Foundations: Biotech VC Larry Bock Uses Start-up Spirit in Science Fest
Read More
Other News To Note
Read More
Stock Movers
Read More
Financings Roundup
Read More
ESMO Roundup
Read More
Clinic Roundup
Read More
Exelixis, BMS Ink More Deals Worth Total Potential $565M
Exelixis Inc. continued its cozy relationship with longtime partner Bristol-Myers Squibb Co., entering two more agreements worth a combined potential $565 million. (BioWorld Today)
Read More
ImmunoGen Gets $45M Up Front from Novartis for TAP
Read More